Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease

Waning immunity following administration of mRNA-based COVID-19 vaccines remains a concern for many health systems. We undertook a study to determine if recent reports of waning for severe disease could have been attributed to design-related bias by conducting a study only among those detected with...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Devendra, Abdulmajeed, Jazeel, Al-Shamali, Maha H. M. A., Albayat, Soha S. A., Himatt, Sayed M., Cyprian, Farhan S., Chivese, Tawanda, Mundodan, Jesha M. A., Khogali, Hayat S., Baaboura, Rekayahouda, Kaleeckal, Anvar H., Kandy, Mujeeb C., Latif, Ali Nizar, Al-Kuwari, Mohamed Ghaith, Al-Romaihi, Hamad Eid, Al Khal, Abdullatif, Bertollini, Roberto, Al-Thani, Mohamed Hamad, Farag, Elmobashar, Doi, Suhail A. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321581/
https://www.ncbi.nlm.nih.gov/pubmed/35891199
http://dx.doi.org/10.3390/vaccines10071036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321581/
https://www.ncbi.nlm.nih.gov/pubmed/35891199
http://dx.doi.org/10.3390/vaccines10071036

Ejemplares similares